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EDITORIAL REVIEW
Hormonal control of renal potassium excretion
Hormonal regulation of potassium excretion by the kidney is
generally thought of principally as a function of aldosterone.
However, recent studies not only redefine the role of aldoste-
rone in this regard but suggest that other hormones may also
contribute toward maintenance of potassium homeostasis by
the kidney under a variety of physiological conditions. This
review will survey what is known of these humoral influences,
emphasizing both the specific effect of each agent on renal
tubular potassium transport, as well as the possible homeostatic
role played by each in maintaining potassium balance under
physiological conditions. The limits of the present article are
that only hormones extrinsic to the kidney will be considered,
leaving aside the possible effects of intrinsic renal hormones,
about which less specific information is available.
The hormonal actions to be discussed will be considered
within the framework of our current conceptions of renal
potassium handling [1, 21. It is thought that potassium is filtered
freely and undergoes extensive proximal reabsorption, resulting
in the presentation of a remarkably constant fraction of the
filtered potassium load to the earliest convolutions of the distal
tubule. The late portions of this nephron segment in the rat
resemble the cortical collecting tubule, both structurally and
functionally [3, 4]. It is in these tubular divisions that potassium
secretion occurs, and the regulation of this process by a variety
of luminal and circulatory factors, including hormones, largely
determines the final level of urinary excretion of potassium [1,
2, 5]. A variable degree of potassium reabsorption generally
occurs along the length of the medullary collecting ducts; this
process is not known to be under direct hormonal control.
Mineralocorticoids
Adrenal corticosteroids
The native mineralocorticoid hormone, aldosterone, has long
been known to influence renal potassium excretion [6]. The
most dramatic manifestations of this effect are the potassium
wasting characteristically found in primary aldosteronism in
humans [7] and the potassium retention seen in untreated
Addison disease [8]. Whether fluctuations in the circulating
aldosterone concentration within a more physiological range
are also important in determining the rate of potassium excre-
tion, however, has been less well documented [9]. Long-term
experiments in dogs have established that high physiological
levels of aldosterone are associated with a reduction in total
exchangeable potassium, and also cause redistribution of potas-
sium from the extracellular to the intracellular fluid compart-
ments [10, 11]. Taken together with the known effect of
hyperkalemia to cause aldosterone release from the adrenal
zona glomerulosa [12], these findings suggest that aldosterone
plays a key role in the feedback control loop by which external
and internal potassium balance are adjusted chronically in
response to fluctuations in dietary potassium intake.
It is not clear, on the other hand, that acute changes in
aldosterone concentration are important in the physiological
regulation of renal potassium excretion. Although a kaliuretic
response to acute mineralocorticoid injection was reported in
several early studies [13, 14], many subsequent investigations,
in general those that used more physiological hormone doses,
have been unable to demonstrate this effect, thereby raising the
question of the true role of aldosterone in modulating short-
term potassium homeostasis [91. Because most of these studies
have been performed in animal models using clearance tech-
niques, it is possible that a direct effect of aldosterone on the
mechanism of tubular potassium secretion may have been
masked by simultaneous changes in other variables—particu-
larly urinary sodium concentration and flow rate—which are
known to be important regulators of distal potassium transport.'
Indeed, a direct stimulatory effect of aldosterone on distal
tubular potassium secretion is suggested both by concentration
gradient data and by electrophysiological results in adrenalec-
tomized rats [18—201. Furthermore, data obtained in cortical
collecting tubules dissected from rabbits treated with chronic
high-dose mineralocorticoid therapy are also consistent with
such an action [21, 22]. However, it is of interest that in no
preparation reported to date has there been a direct demonstra-
tion of an acute effect of the hormone in physiological doses on
transepithelial potassium fluxes.
To clarify the acute, direct influence of adrenal corticoster-
oids on tubular potassium handling, we recently performed a
series of transport experiments in adrenalectomized rats, which
were studied after 8 to 10 days of treatment with basal replace-
ment doses of both aldosterone and dexamethasone (a rela-
tively pure glucocorticoid). Using this baseline, the effect of
acute infusions of either of the two corticosteroids alone, given
in appropriate doses, could be examined specifically [23].
Furthermore, we used this model to define the influence of
hyperkalemia per se on renal potassium transport, since potas-
sium chloride could be infused without provoking a reactive
increase in aldosterone levels, such as that which occurs in the
presence of intact adrenals [24]. To evaluate direct effects on
epithelial function in the absence of secondary alterations in
luminal fluid composition and flow rate, we measured tubular
potassium secretion in individual distal tubules microperfused
at a constant rate in situ, while at the same time collecting final
It should be pointed out that the stimulatory effect of increased sodium
delivery on distal tubular potassium secretion has been shown to be due
to the effect of increased tubular flow rate per se, rather than luminal
fluid sodium concentration, under physiological conditions [15, 161.
However, changes in sodium concentration may play an important role
in regulating potassium secretion by the cortical collecting tubule [171.
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Fig. 1. Key results of clearance and microperfusion studies in
adrenalectomized rats. All animals were given basal replacement doses
of aldosterone and dexamethasone for 8 to 10 days prior to the study, at
which time they received one of the five acute treatments shown.
Abbreviations are: V, final urinary flow rate; UKV (), final urinary
potassium excretion; JK (D), potassium secretion by distal tubules
microperfused in vivo at a constant rate; [K], plasma potassium
concentration (mM) (based on data in [23]).
ureteric urine to record changes in overall renal excretion
patterns.
Some key results of these experiments are shown in Figure 1.
Considering first the effects of acute aldosterone, it is clear that
this infusion stimulated potassium secretion in distal tubules
studied under the controlled conditions of microperfusion.
Significantly, however, it was also noted that final urinary
potassium excretion, measured at the same time, was not
increased. A likely explanation for this disparity is that urinary
flow rate was reduced markedly by aldosterone, secondary to
its powerful antinatriuretic effect. Under free-flow conditions,
this change may have opposed and thus attenuated the
hormone's direct stimulatory effect on distal potassium
secretion.
Similar observations were made when aldosterone was in-
fused during hyperkalemia (last two columns in Fig. 1): While
hyperkalemia itself was an effective stimulus to both the tubular
secretion and final urinary excretion of potassium, the super-
imposition of an acute infusion of aldosterone led to a further
enhancement only of transport by microperfused tubules; the
urinary potassium excretion rate was unchanged. As also
shown in Figure 1, however, the mean plasma potassium
concentration reached during combined potassium chloride,
and aldosterone infusion (6.6 mM) was significantly lower than
during infusion of potassium chloride alone (7.3 mM), implying
that the hormone enhanced extrarenal disposal of the infused
potassium load. This property of aldosterone has recently
received increased reportage [10, 25].
These results have important implications for understanding
the physiology of renal potassium handling in a variety of
circumstances, as well as explaining some of the variability in
previous clearance studies. The following are some relevant
points of interest.
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Fig. 2. Homeostatic interactions tending to minimize disturbances in
distal tubular potassium secretion during acute reduction in extracel-
lular fluid (ECF) volume (top panel), and water deprivation (lower
panel). The converse changes to those shown here develop during acute
perturbations in the opposite direction (ECF expansion and water
loading).
Maintenance of potassium homeostasis during extracellular
volume changes. It is clear from the above that acute fluctua-
tions in aldosterone levels, such as those associated with abrupt
changes in extracellular volume status, do not necessarily lead
to alterations in potassium excretion, largely because of the
opposing effect of changes in the flow rate of fluid traversing the
potassium secretory sites (late distal and cortical collecting
tubules; see top panel of Fig. 2). For example, during an acute
reduction in extracellular fluid volume, a rise in aldosterone,
tending to stimulate distal potassium secretion, occurs simul-
taneously with a fall in distal flow rate, tending to depress
secretion. Two factors probably contribute to the slowing of
distal flow under these conditions. First, enhanced proximal
tubular fluid reabsorption is triggered by the fall in blood
volume, and this alone reduces fluid delivery into the distal
tubule [261. Second, our own results suggest that aldosterone
itself may lower urinary flow rates, presumably as a conse-
quence of increased sodium reabsorption along segments of the
distal nephron.
It is of interest in relation to the above discussion that several
previous studies demonstrated that the kaliuretic effect of
aldosterone is most noticeable under conditions of sodium
loading, but disappears when salt is relatively restricted [27,
281. In line with the foregoing arguments, this phenomenon can
be attributed to the influence of the prevailing sodium status on
the rate of fluid delivery through the distal nephron, such that
the lowest urinary flow rates develop during low salt states.
Although aldosterone fails to stimulate potassium excretion
under these circumstances, we would propose, in physiological
terms, that such conditions represent an appropriate context for
definition of the acute effects of this hormone.
In contrast to the balanced reciprocal changes in aldosterone
levels and urinary flow rates maintaining potassium balance
during normal volume regulation, marked disturbances in these
relationships can occur in certain pathophysiological situations.
Thus, in conditions of secondary aldosteronism due to low
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Table 1. Summary of changes in sodium and potassium transport
during acute and chronic treatment with rnineralocorticoid
Acute Chronic
Sodium
Proximal reabsorption N
Distal reabsorption C C
Urinary excretion Na
Potassium
Distal: flow effect N or N
Distal: direct effect C C
Urinary excretion or N a
Abbreviation: N, indicates normal (unchanged).
a Findings during mineralocorticoid "escape" are indicated.
effective arterial volume (for example, congestive heart failure),
significant urinary potassium wasting can be provoked by the
administration of diuretics, because here the presence of high
aldosterone levels coincides with high rates of flow through the
distal tubule, induced by the diuretic agent [29].
Response to acute potassium loading. A second implication
of our data concerns the role of the sharp rise in aldosterone
release which accompanies acute potassium loading in the
intact animal [24]. Since absolute potassium excretion was not
enhanced by acute aldosterone during potassium chloride infu-
sion in our experiments (last two columns in Fig. 1), it may be
deduced that maximal rates of renal clearance of an acute
potassium load do not require an associated acute increase in
circulating aldosterone above basal levels, but are mediated
largely by the increases in plasma potassium concentration and
urinary flow rate which accompany this maneuver. It would
appear that the surge in aldosterone serves chiefly to improve
the animal's tolerance to the acute potassium load, since the
rise in plasma potassium concentration was considerably less
with supplementary aldosterone infusion than without. As
mentioned earlier, this phenomenon is due to the effect of
aldosterone to enhance potassium uptake by extrarenal tissues
[10, 25].
Chronic effects of aldosterone. It is necessary to place these
observations in context to explain the established chronic
influence of aldosterone on renal potassium handling [7, 10, 11].
During prolonged exposure to elevated levels of mineralocorti-
coids, it is well-known that escape occurs from the sodium-
retaining properties of these agents, whereas renal potassium
losses continue and result ultimately in a state of potassium
depletion [8, 30]. Although this disparity has been used as an
argument for separate mechanisms of aldosterone action on
sodium reabsorption and potassium secretion, we believe that a
more likely explanation is that the balance between the direct
and flow-mediated actions of aldosterone on potassium trans-
port is different in the acute and chronic phases of mm-
eralocorticoid treatment. Thus, as shown in Table 1, urinary
sodium excretion is reduced in the acute phase due to stimula-
tion of sodium reabsorption in the distal nephron and is ac-
companied by unchanged or minimally elevated rates of potas-
sium excretion, for the reasons outlined above. However,
during more prolonged treatment, sodium excretion is normal-
ized, because of the effect of progressive plasma volume
expansion to inhibit proximal tubular sodium and water reab-
sorption [31]. This, in turn, restores distal flow to normal levels
and allows expression of the stimulatory effect of the hormone
on potassium excretion (Table 1). This interpretation thus
provides a basis for the observation that long-term fluctuations
in aldosterone levels, such as those seen in response to changes
in dietary potassium intake, can in fact modulate urinary
potassium excretion, whereas less consistent effects are seen in
the shorter term because of the opposing influence of urinary
flow-rate changes.
An important role for aldosterone has also been defined in
contributing to the phenomenon of adaptation to a high potas-
sium diet. It has been known for many years that the excretory
response to an acute potassium load is enhanced, and the
associated rise in plasma potassium concentration blunted, by a
preceding period of high potassium intake, and that such
tolerance is abolished by adrenalectomy and restored by re-
placement with exogenous mineralocorticoid [32, 33]. Further-
more, adaptation is associated with an increase in NaK-ATPase
activity in those distal nephron segments, such as the cortical
collecting tubule, responsible for potassium secretion [341, and
the same enzymatic stimulation can be produced by mineralo-
corticoids [351. A more difficult question, however, has been
whether the increase in ATPase, and the process of adaptation,
require small (permissive) amounts of aldosterone, or whether
the high levels of aldosterone which in fact develop during
adaptation [24] are necessary. Investigation of this problem is
complicated by the fact that adrenalectomized animals do not
survive chronic or acute potassium loading unless some form of
corticosteroid replacement is given. To date, however, such
replacement has generally been at an inappropriately high level
in relation to basal hormone secretion rates [36]. Hence,
conclusions as to the quantitative role of aldosterone in adapta-
tion have been somewhat tentative [37].
Recently, a more conclusive result has been provided in a
preliminary study in which adrenalectomized rats were fed a
high potassium diet during treatment with physiologically low
and high levels of aldosterone [38]. Because cortical collecting
tubule NaK-ATPase was stimulated significantly by the high-
potassium diet only during high dose aldosterone replacement,
it seems likely that elevated endogenous mineralocorticoid
levels are in fact necessary for the development of adaptation in
vivo. Finally, it should be mentioned that an important role
exists for extrarenal mechanisms in the adaptive response,
since the phenomenon of tolerance has been demonstrated in
totally nephrectomized rats previously fed a high potassium diet
[39]. This effect also appears to depend on aldosterone.
Cellular mechanism of mineralocorticoid action. The mecha-
nism of the direct effect of aldosterone on epithelial potassium
secretion has been investigated principally with electrophysi-
ological techniques. An early series of experiments on the rat
kidney in vivo [19, 20, 40] suggested that the response of the
late distal tubule to aldosterone could be interpreted in terms of
two components: a stimulatory action on the uptake of potas-
sium at the basolateral membrane and an effect on the apparent
potassium permeability of the luminal membrane. Sodium reab-
sorption is also known to be stimulated by aldosterone in this
nephron segment, and the resulting increase in the electrical
negativity of the lumen [41] would also favor potassium
secretion.
More detailed information concerning the cellular events
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Table 2. Comparison of kaliuresis induced by mineralocorticoids and
glucocorticoids
Mineralocorticoids Glucocorticoids
GFR Unchanged Usually increased
Sodium excretion Reduced Usually increased
Urine flow rate Acutely reduced Usually increased
Time course Delayed, sustained Rapid, transient
Dietary factors
Na depletion Prevents kaliuresis No effect
K repletion" Prevents kaliuresis No effect
Plasma [K] Usually falls Often rises
Effect of spironolactone Blocks kaliuresis No effect
a Sources used are [19, 45—50].
K repletion refers to the influence of a normal diet, compared to a
period of K-depletion, prior to hormone treatment in adrenalectomized
animals.
involved in stimulation of potassium secretion by miner-
alocorticoids has been provided recently by microelectrode
studies of the isolated cortical collecting tubule of the rabbit
[42—441. In this preparation, chronic pretreatment of animals
with the mineralocorticoid DOCA results in an increase in the
transepithelial potential difference, due to both depolarization
of the apical membrane and hyperpolarization of the basolateral
membrane, the latter presumably the result of stimulation of
electrogenic ATPase pump activity. Experiments using ion
substitutions and specific channel blockers indicate that the
apical membrane conductances to both sodium and potassium
are increased after DOCA. Thus, enhanced potassium secretion
is likely to result from the combined effects of (1) increased
basolateral uptake (by both active and electroconductive path-
ways), (2) an increased electrochemical gradient favoring move-
ment across the apical membrane from the cell into the lumen,
and (3) increased potassium conductance of the luminal mem-
brane.
Glucocorticoids
It has been recognized for several decades that infusion of
glucocorticoid steroids can increase renal potassium excretion
[45—47]. Several groups of investigators have drawn attention to
differences between this glucocorticoid-type of kaliuresis and
that classically associated with mineralocorticoid activity ([45,
48—50]; see Table 2). Thus, it usually has been observed that,
coincident with stimulation of urinary potassium excretion,
glucocorticoids produce increases in glomerular filtration rate
(GFR), and frequently also in sodium excretion and urinary
flow rate, whereas these changes are rarely observed after
mineralocorticoids (except in pharmacological doses) [46, 47,
50]. Furthermore, glucocorticoid kaliuresis usually ensues more
rapidly and is of shorter duration than that following
mineralocorticoids [48]. While the kaliuretic response to aldo-
sterone is blunted in animals on a low sodium [27] or normal
potassium [19] intake, these dietary factors are without effect
on the response to glucocorticoids [48, 501. The plasma potas-
sium concentration is usually normal or elevated during gluco-
corticoid treatment, but often falls with mineralocorticoids [481.
Finally, the increase in potassium excretion after aldosterone
and related steroids can be inhibited by the mineralocorticoid
receptor-blocker spironolactone, which does not affect the
response to glucocorticoids [47, 50].
These observations suggest that the aldosterone-type of
kaliuresis represent a direct tubular effect, produced by a
receptor-mediated alteration in tubular potassium transport. In
contrast, stimulation of urinary potassium excretion following
dexamethasone and related agents may be purely secondary to
hemodynamic effects and associated changes in luminal condi-
tions. We recently tested this hypothesis, in conjunction with
the microperfusion study of aldosterone action described above
[23]. As shown in the middle column in Figure 1, when distal
tubules of adrenalectomized rats were perfused in vivo at a
constant rate, acute intravenous infusion of dexamethasone had
no effect on the rate of net potassium secretion in the perfused
tubules, while final urinary potassium excretion was enhanced,
along with increased excretion of sodium and fluid. This result
suggests that increased potassium excretion after dexametha-
sone is indeed a consequence of increased fluid delivery rates
into the distal tubule, secondary to improvement in GFR, rather
than being a direct effect on the tubule itself. This interpretation
is consistent with an earlier micropuncture study [511 showing
that the depressed transepithelial potassium concentration gra-
dient in the late distal tubule of adrenalectomized rats could not
be normalized by dexamethasone.
These data are also interesting relative to recent clearance
studies that examine the role of glucocorticoids in modifying the
capacity of adrenalectomized rats to excrete an acute potassium
load (Stanton, Giebisch, Klein-Robbenhaar, Wade, and
DeFronzo, to be published [52—531). In these studies, pretreat-
ment of animals with dexamethasone in low doses was shown to
enhance the absolute urinary excretion of potassium, and so
improve potassium tolerance, compared to that observed in
untreated animals. Although this improvement was generally
found to be comparable to that observed with aldosterone
treatment, the mechanism of the increase in urinary potassium
excretion was clearly different in the two cases. Thus, GFR and
urinary flow rate were found to be increased only in the
dexamethasone-treated group, which achieved a lower frac-
tional rate of potassium excretion than the aldosterone-treated
group (Stanton, Giebisch, Klein-Robbenhaar, Wade, and
DeFronzo, to be published), a result consistent with the direct
microperfusion findings cited above.
The results of microperfusion and clearance studies dis-
cussed in the foregoing paragraphs strongly suggest that elec-
trolyte transport in distal nephron segments is under the control
of mineralocorticoid rather than glucocorticoid steroids. Ad-
ditional evidence supporting this view has come from recent
investigations using morphological and biochemical techniques
(see Table 3). Thus, it has been shown that the reduction in
basolateral membrane area of principal cells, following adrenal-
ectomy in rats, is restored to normal by basal doses of aldos-
terone, but not dexamethasone (Stanton, Janzen, Klein-
Robbenhaar, DeFronzo, Giebisch, and Wade, to be published).
Furthermore, the degree of amplification of the basolateral
membrane area in this cell type has a direct relationship with
plasma aldosterone levels over a wide range [54]. Similarly,
biochemical studies of NaK-ATPase activity in distal nephron
segments generally show a marked depression of activity after
adrenalectomy. Normalization of this change, in the cortical
collecting tubules of both the rabbit [551 and the rat [56], is
produced by mineralocorticoid but not glucocorticoid hor-
mones. Finally, our recent microperfusion studies, together
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Mineralocorticoid Glucocorticoid
Refer-
ences
Morphology Modulation of principal cell
basolateral membrane
area (physiological doses)
No effects in
physiological
doses
55, 56
Biochemistry Regulation of NaK-ATPase
(physiological doses)
No effects in
physiological
doses
57, 58
Transport Direct stimulation of Na
and K fluxes
No direct
effects
22, 23,
51
with earlier micropuncture and isolated collecting tubule data,
confirm the ability of aldosterone, but not dexamethasone, to
modulate transepithelial potassium transport in distal nephron
segments.
Despite the absence of a direct stimulatory effect of
glucocorticoids on tubular potassium secretion, we would spec-
ulate that this class of steroids may play an important sup-
portive role in regulating the overall process of potassium
excretion. Thus, by partly determining the hemodynamic state
of the kidney, and hence the rate of fluid delivery through the
nephron, glucocorticoids may set the level of sensitivity of the
distal tubule to other regulatory influences, and hence act in
concert with aldosterone to determine the final rate of urinary
potassium excretion.
Antidiuretic hormone
Two types of observation suggest that ADH may, either
directly or indirectly, influence renal tubular potassium
transport.
First, an increase in potassium excretion has been noted
frequently to follow ADH administration to intact animals,
despite a reduction in urinary flow rate and a variable effect on
sodium excretion [57—60]. Second, it has been observed gener-
ally that water diuresis is ineffective in elevating urinary potas-
sium excretion rates, in contrast to the marked stimulation
obtained by an equivalent diuresis associated with a urinary
solute load [61, 62]. One conceivable explanation for this
finding is that suppression of ADH levels by water loading may
itself act to limit the intrinsic capacity of the potassium secre-
tory apparatus, and thereby make potassium excretion rela-
tively independent of variations in water balance.
To explore the possibility of a direct effect of ADH on tubular
potassium secretion, we conducted transport studies in
homozygous Brattleboro rats, which are congenitally deficient
in the hormone [63]. Clearance experiments did in fact reveal a
modest enhancement of potassium excretion after conversion
of water diuresis to antidiuresis by an acute infusion of ADH.
Collections of distal tubular fluid under free-flow conditions
demonstrated that this effect was not established by the end of
the accessible distal tubule; indeed, the estimated net secretory
flux of potassium along this tubular segment was negligible in
this model both before and after ADH infusion (see Fig. 3, top
panel). Since, however, the rate of fluid flow through the late
distal tubule was reduced significantly by ADH (secondary to
increased water reabsorption), we were unable from these data
to exclude a direct effect of ADH on potassium secretion in this
segment. Also, because the fall in distal luminal flow rate alone
would have been expected to inhibit potassium secretion, it
seemed likely that ADH may have exerted an opposing stimula-
tory action, resulting in no net effect on transport by the end of
the tubule.
This prediction was confirmed in a second series of experi-
ments, in which distal tubules were microperfused in vivo at a
constant rate using a fluid made isotonic by the addition of a
nonreabsorbed solute (urea). Under these conditions, water
reabsorption was negligible in the presence as well as the
absence of ADH in the circulation. As shown in the lower panel
of Figure 3, this design permitted potassium transport to be
studied at constant luminal flow rate. We note that a marked
stimulation of net potassium secretion by the distal tubule was
now apparent from ADH.2 Sodium transport was not signifi-
cantly affected by ADH in these protocols, although it should
be pointed out that other investigators have found an enhance-
ment of sodium reabsorption by the distal tubule under similar
conditions [64].
2The higher control values of potassium secretion obtained in
microperfused tubules, compared to tubules studied under free-flow
conditions, are probably due to the higher luminal flow rate and sodium
concentration chosen to perform the microperfusion experiments.
Table 3. Evidence for mineralocorticoid versus glucocorticoid control
of electrolyte transport by the distal nephron (initial and cortical
collecting tubules)
C
Free-flow micropuncture
10 20
E
5 10
0 0
ADH C ADH
Continuous microperfusion
10 20
I
0 0 I I
C ADH C ADH
Fig. 3. Comparison of changes recorded in late distal tubular flow rate(VLD), and in potassium secretion by the distal tubule (JK), during
free-flow micropuncture (top panel) and distal tubular inicroperfusion
(bottom panel) when ADH is infused into Brattleboro rats. See text for
details (based on data in [65]).
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Fig. 4. Schematic model of cell from the initial or cortical collecting
tubule of the rat, showing possible pathways involved in mediating
transport changes in response to ADH. Abbreviations are: AC, ade-
nylate cyclase; cAMP, cyclic adenosine monophosphate; PK1, PK2,
and PK3, putative classes of phosphokinase involved in altering apical
membrane conductive properties to water, sodium, and potassium. The
direction of enhanced passive movement of each of these species is
indicated by the broken arrows passing through channels in this
membrane.
Very recently, preliminary data confirming this effect of ADH
on potassium secretion have become available in isolated
cortical collecting tubules (CCT). Whereas earlier studies, using
the rabbit CCT in vitro, found only transient electrical and ion
flux responses to ADH [65, 66], experiments using CCTs
dissected from pathogen-free rats show sustained stimulation
by ADH of potassium secretion, and also of sodium reabsorp-
tion, at least in animals pretreated with DOCA (Tomita, Pisano,
and Knepper, personal communication). Moreover, studies
with this preparation, using 86Rb + as a marker for potassium,
have suggested that this stimulation results solely from en-
hanced bath-to-lumen flux, the lumen-to-bath transfer being
unaffected (Troutman and Schafer, personal communication).
Mechanism of ADH effect. Only limited information is avail-
able on the mechanism whereby ADH promotes net secretion
of potassium in renal epithelia. A priori, one might suppose that
the effect may be purely secondary to the simultaneous stimula-
tion in net sodium reabsorption found in most of the studies
cited, since the attendant increase in luminal negativity would
favor potassium movement into the lumen across the apical cell
membrane and/or the intercellular shunt pathway. On the other
hand, indirect evidence suggests that a likely additional or
alternative mechanism may be an increase in apical membrane
potassium conductance, induced as a consequence of ADH
binding at the basolateral cell membrane (Fig. 4). Such a
mechanism, analogous to the processes previously implicated
to account for ADH-stimulated transfer of water [67] and
sodium [681 across target epithelia, receives support from
recent work in several urinary tissues. In toad urinary bladder,
for example, Palmer [69] has presented electrical evidence
consistent with an increased potassium conductance of the
apical membrane following serosal addition of ADH. Further-
more, Hebert, Friedman, and Andreoli [70] recently proposed,
from their data in the mouse medullary thick ascending limb,
that an increase in luminal potassium conductance plays a role
in the stimulation of sodium chloride cotransport by ADH in
this nephron segment. Finally, a very direct but preliminary
examination, using the patch-clamp technique, revealed the
presence of ADH-stimulated potassium channels in the apical
membrane of cultured chick kidney cells (Guggino, personal
communication). Whether this putative effect on the apical
membrane is mediated by insertion of new membrane struc-
tures, or, as has been proposed for sodium [71], by activation of
potassium channels already present in this membrane, is cur-
rently unknown.
Sign jficance of ADH effect. The finding of a direct stimula-
tory action of ADH on renal tubular potassium secretion may
have significance for the regulation of potassium excretion
under a variety of conditions. In particular, it may have
implications for the pathophysiology of potassium metabolism
in certain situations of clinical interest. For example, potassium
wasting and hypokalemia are sometimes found in the syndrome
of inappropriate ADH secretion [72—74], when ADH levels are
chronically and pathologically elevated. Second, it appears that
acute potassium tolerance is improved by ADH. Thus, in one
study utilizing Brattleboro rats it was found that these animals
did not excrete an acute potassium load as well as rats having
normal ADH levels [75], while in another study, the develop-
ment of hyperkalemic cardiotoxicity in potassium-infused dogs
was delayed by simultaneous treatment with ADH [76]. Third,
it is possible that the acute stimulation of ADH release which
follows treatment with potent loop diuretics may contribute to
the urinary potassium loss which occurs in this setting. This
follows from the observation that the acute kaliuresis is reduced
if the diuretic is given during water diuresis rather than
hydropenia [77].
This action of ADH may also have implications for the
maintenance of potassium homeostasis during different states of
water balance. Thus, the fall in flow rate through the distal
nephron which follows ADH release during hydropenia would
itself be expected to depress potassium secretion. However, an
opposing action of the hormone to stimulate the secretory
mechanism (lower panel of Fig. 2) may be responsible for the
minimal alteration in potassium excretion which is in fact
observed during water deprivation. A converse argument may
account for the failure of potassium excretion to increase during
water diuresis, since in this situation urinary flow rate is high
but ADH levels are low.
Catecholamines
It has been well established that epinephrine contributes
importantly to the regulation of the plasma potassium concen-
tration, by virtue of its property of enhancing potassium uptake
by extrarenal tissues [78, 79]. This effect on the internal balance
of potassium, apparently mediated by stimulation of the cell
membrane NaK-ATPase in response to activation of peripheral
132 receptors [80], plays a key role in determining the organism's
acute tolerance to an administered potassium load. It has also
been noted that infusions of epinephrine often lead to a reduc-
tion in renal potassium excretion [79, 811. However, if it difficult
to determine from whole animal clearance studies whether this
is a direct effect of the hormone on renal tubular potassium
transport, or whether it is a secondary consequence of the sharp
fall in plasma potassium concentration which occurs during
epinephrine administration.
ADR
H20 channels
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Fig. 5. Free-flow micropuncture study of the influence of epinephrine
(epi) on potassium transport along the distal nephron. Results from
three groups of rats are shown—see text for details. [K] represents
plasma potassium concentration (mM) for each experimental group
(based on data in [85]).
Recent experiments have established that the inhibitory
effect of epinephrine on renal potassium secretion does, in fact,
include a direct tubular component. Thus, in studies using the
isolated perfused rat kidney, Katz, D'Avella, and DeFronzo
[82] found that the addition of epinephrine to the perfusate in
stress doses led to an abrupt fall in potassium excretion in the
absence of changes in perfusate potassium concentration. Fur-
thermore, it was also shown in this preparation that this effect
of epinephrine is mediated by the f adrenergic receptor [821, in
contrast to the /3 mediation of extrarenal potassium uptake by
the same hormone [80].
Further characterization of this phenomenon was provided in
a recent free-flow micropuncture study [831. Here it was again
found that epinephrine sharply inhibited the renal excretion of
an infused potassium load. This inhibition was evident at the
level of the late distal tubular collection site when equivalent
potassium doses were infused into control (high K) and epi-
nephrine (high Klepi) groups of rats (see Fig. 5). Since, how-
ever, the epinephrine-infused animals had significantly lower
plasma potassium concentrations, the lower fractional delivery
of potassium to the late distal tubule in this group may have
been due solely to the influence of the lower plasma potassium
on the potassium-secretory mechanism in the distal tubule [24].
To address this question, a further group of control animals was
studied during the infusion of a lower dose of potassium, so as
to match the plasma potassium concentration obtained in the
high Klepinephrine group. Under these conditions, late distal
delivery of potassium was similar in this low K group compared
to that previously observed for high Klepi rats (Fig. 5). How-
ever, a clear inhibition of potassium secretion beyond the late
distal puncture site was now evident, since final urinary excre-
tion of potassium was still lower in the epinephrine-treated
animals.
The possibility that catecholamines exert a direct effect on
transport across the CCT is suggested by the demonstration of
specific receptor sites for isoproterenol in this tubule segment
[84]. Confirmation of an inhibitory action of catecholamines on
potassium secretion by the CCT has also been obtained recently
from in vitro microperfusion experiments [85]. When
isoproterenol was added to the solution bathing isolated
perfused rabbit CCTs, a significant fall in net potassium secre-
tion was observed, in parallel with a fall in transepithelial
potential difference. Since cyclic AMP produced similar effects,
it seemed likely that the catecholamine action was mediated by
cyclic AMP-dependent events. However, little is known about
the cellular mechanism by which potassium transport is altered
by catecholamines in this epithelium. One possibility is that
secretion is inhibited secondary to the depolarization of the
transepithelial voltage, if this is due to hyperpolarization of the
apical membrane potential. Alternatively, or in addition, epi-
nephrine may cause a decrease in the potassium conductance of
the apical membrane, analogous to its effect in rat soleus muscle
[861. These speculations await direct clarification by further
studies using intracellular microelectrode techniques in the
isolated CCT preparation.
The physiological significance of the inhibitory effect of
catecholamines on renal potassium secretion is unclear. Be-
cause a powerful primary action of these hormones is to affect
translocation of potassium from extracellular to intracellular
sites under conditions of stress, the direct effect on the kidney
to reduce potassium excretion may be viewed as a parallel
action to minimize acute depletion of extracellular potassium,
and the associated deleterious consequences of hypokalemia.
Concluding remarks
We would like to conclude this review by stressing a theme
common to our analysis of the three hormone classes surveyed.
Since the final level of urinary potassium excretion is subject to
regulation by several interacting influences, it can be misleading
to deduce from clearance-type experiments what the specific
action of a particular hormone may be at the level of the
potassium secretory mechanism of the tubules. In discussing
the influence of the corticosteroid hormones and ADH on
potassium handling, we have emphasized the importance of
considering concomitant changes in the flow rate of tubular
fluid, while in relation to the catecholamines, we have stressed
the role of simultaneous changes in plasma potassium concen-
tration. These considerations draw attention to the need to use
experimental protocols and techniques designed to hold other
factors constant when studying the specific regulatory influence
of hormones on the process of renal tubular potassium
transport.
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